Additionally, M2 type TAM-derived exosomes may promote osimertinib resistance in NSCLC via the MSTRG.292666.16/miR-6836-5p/MAPK8IP3 axis. The gene discussed is MAPK8IP3; the disease is non-small cell lung carcinoma.